Atlas Trials

Neurophysiological and Biomolecular Effects of Atogepant in Episodic Migraine

Clinical trial NCT06882122 · RECRUITING

Trial details

NCT number
NCT06882122
Sponsor
IRCCS National Neurological Institute "C. Mondino" Foundation
Status
RECRUITING
Study type
OBSERVATIONAL
Migraine DisorderEpisodic Migraine
Start date
2024-12-01
Primary completion
2025-12-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.